Therapeutic assessment of substrate deprivation using NB-DGJ in GM1 storage disease mice

Documenti analoghi

• Substrate deprivation therapy reduces brain ganglioside content and GM1 in neonatal storage disease mice
  di: Kasperzyk, J, et al.
  Pubblicazione: (2002)
• Effects of substrate deprivation therapy on brain lipids in neonatal GML storage disease mice
  di: Kasperzyk, J, et al.
  Pubblicazione: (2003)
• "Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice" (vol 46, pg 744, 2004)
  di: Kasperzyk, J, et al.
  Pubblicazione: (2005)
• Erratum: Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice (Journal of Lipid Research (April 2004) 46 (744-751))
  di: Kasperzyk, J, et al.
  Pubblicazione: (2005)
• N-butyldeoxygalactonojirimycin reduces postnatal cerebellar ganglioside content in a mouse model of GM1 gangliosidosis
  di: Kasperzyk, J, et al.
  Pubblicazione: (2004)